DXCM Filing
4Filing Date: Jun 1, 2026

DEXCOM INC (DXCM) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001093557-26-000119open_in_new
Total Value$0
Trades1
Insiders1

Transaction Details

Driscoll Rimma
Director·Direct
Grant · Acquire
Common Stock
Shares+5.61K
Price$0.00
Total Value$0
Shares Owned After17.32K
Transaction DateMay 28, 2026
Footnotes ▸

The RSU Award was granted on May 28, 2026 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. | Included in this number are 6,941 unvested restricted stock units, 5,605 of which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders, and 1,336 of which were granted on August 24, 2023 and shall vest through August 24, 2026.

Post-Transaction Holdings

Driscoll Rimma
SecuritySharesChange
Common Stock17.32K+5.61K (47.85%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-28 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: DEXCOM INC (DXCM) CIK: 0001093557 --- Reporting Owner --- Name: Driscoll Rimma CIK: 0001952575 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-05-28 | Code: A (Grant or award) Shares: +5,605 | Price: $0.00 Shares Owned After: 17,319 | Ownership: D (Direct) Footnotes: [F1] The RSU Award was granted on May 28, 2026 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. [F2] Included in this number are 6,941 unvested restricted stock units, 5,605 of which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders, and 1,336 of which were granted on August 24, 2023 and shall vest through August 24, 2026. --- Footnotes (Complete Index) --- F1: The RSU Award was granted on May 28, 2026 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F2: Included in this number are 6,941 unvested restricted stock units, 5,605 of which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders, and 1,336 of which were granted on August 24, 2023 and shall vest through August 24, 2026. --- Signature --- /s/ /s/ Jereme M. Sylvain, as Attorney-in-Fact for Rimma Driscoll (2026-06-01)

keid AI analysis is for reference only and does not constitute investment advice.